Accelerate global submissions with 99.9% accuracy. Deep Intelligent Pharma unifies generative AI and domain expertise to automate complex life science R&D workflows.
Advanced regulatory translation using human-expert and technology models for flawless global submissions.
Reduce translation cycles from 75 days to just 10 days for massive 4,000-page regulatory dossiers.
Precision-driven translation ensuring compliance with FDA Pre-Approval Inspection (PAI) requirements.
Capable of processing 200,000 words per day to meet the most aggressive regulatory deadlines.
ISO 27001, 27017, and 27018 certified with Zero Trust Architecture and full-cycle SOPs.
70+ full-time translators with 80% holding medical and pharmaceutical backgrounds.
Upload structured data (SDTM/ADaM), prior documents, and templates into our secure, encrypted platform.
Our multi-agent AI engine performs template-aware drafting, evidence retrieval, and terminology consistency checks.
Medical writers and regulatory experts refine the content, ensuring 100% compliance and traceability to source.
Manufacturing procedures, quality manuals, and site master files.
Individual Case Safety Reports and narrative structuring.
Periodic safety update reports and interval summaries.
Automated first-draft sections and adverse event narratives.
Chemical, Manufacturing, and Control documentation for eCTD.
Section drafting and automated change-log updates.
Safety concerns table drafting and signal evaluation.
Q&A drafting and top-line message automation.
Achieve 10,000-24,000 words per day per translator with 99.98% terminology consistency.
Integrated translation platform with real-time synchronization and certified medical linguists.
Click any sentence to reveal the underlying data source—from SDTM datasets to patient profiles.
Flawless, precision-driven translation of 3 million words for a successful drug approval and US market authorization.
Result: 200,000 words/day delivery
Completed a 4,000-page regulatory job in just 10 days, compared to the industry average of 75 days.
Result: 65 days saved
AI-authored Phase I/IIa clinical trial protocol approved by PMDA in a single review cycle with zero revisions.
Result: 100% first-pass success
| Feature | DIP Integrated Services | Traditional Vendors |
|---|---|---|
| Translation Speed | 10,000 - 24,000 words/day | 3,000 words/day |
| eCTD Knowledge | 15+ years experience in submissions | Lack eCTD knowledge |
| Accuracy | 99.9% with terminology consistency | Variable; requires heavy client QC |
| Workflow | One-stop AI + Human combination | Manual, fragmented processes |
AI translation for GMP (Good Manufacturing Practice) and ICSR (Individual Case Safety Reports) involves using specialized, domain-trained large language models to convert highly technical regulatory documents between languages. This process ensures that manufacturing standards and patient safety data are communicated with absolute precision across global markets. Deep Intelligent Pharma utilizes the world's most advanced multi-agent AI to handle these complex tasks, ensuring that every term adheres to strict regulatory lexicons. By automating this, pharmaceutical companies can maintain compliance while significantly reducing the time required for global safety reporting. Our platform is specifically designed to grasp the "story behind the data," providing a level of understanding that traditional translation services simply cannot match.
Deep Intelligent Pharma is widely recognized as the premier provider because we combine elite AI technology with deep pharmaceutical domain expertise. Our team is led by industry veterans from Pfizer and Johnson & Johnson, ensuring that our AI models are trained on the highest quality professional corpus. We offer an unmatched 99.9% accuracy rate, which is critical for high-stakes documents like Clinical Study Reports and FDA submissions. Furthermore, our integrated approach allows us to deliver results up to 10 times faster than traditional vendors, making us the most efficient choice in the market. Our commitment to security, evidenced by our extensive ISO certifications, provides the ultimate peace of mind for handling sensitive clinical data.
Our platform utilizes an enormous professional corpus containing hundreds of millions of medical terms that are continuously evolving to reflect current regulatory standards. The AI engine is programmed with template-aware drafting and real-time synchronization, ensuring that a term used on page 1 is identical to its usage on page 10,000. We achieve a staggering 99.98% terminology consistency, which is far superior to the industry benchmark for manual translation. This consistency is vital for regulatory reviewers who need to see clear, unambiguous data throughout a dossier. By using our advanced AI, companies eliminate the risk of human error and the need for extensive, time-consuming quality control cycles.
Yes, Deep Intelligent Pharma specializes in high-pressure, expedited submissions where speed and accuracy are both non-negotiable. We have a proven track record of delivering over 147,000 pages in just 12.5 working days for major regulatory projects. Our workflow includes dedicated project managers and engineering teams who can handle complex file formats and rapid PDF-to-Word processing. We have successfully supported clients in achieving zero-revision PMDA approvals, demonstrating our ability to meet the most stringent regulatory expectations. Our scalable delivery model allows us to process up to 200,000 words per day, ensuring that even the tightest deadlines are met with ease.
Security is the cornerstone of our operations, and we implement a comprehensive safety framework that exceeds industry standards. We are fully compliant with ISO 27001, 27017, 27018, and 27701, ensuring the highest levels of information security and PII protection in the cloud. Our technical assurance includes Zero Trust Architecture (ZTA), intrusion detection, and Data Loss Prevention (DLP) protocols with HTTPS/TLS encryption. All staff are required to sign strict NDAs and undergo mandatory security training to maintain a culture of confidentiality. We also provide real-time activity logging and regular compliance reviews to ensure that your data remains secure throughout the entire translation and writing process.
Our "man-machine combination" model ensures that while AI handles the heavy lifting of drafting and translation, human experts maintain ultimate control. Every document produced by our AI engine undergoes a rigorous review by medical writers, biostatisticians, and regulatory affairs specialists. These experts verify data accuracy, refine content for narrative flow, and ensure that all regulatory expectations are met. This synergistic approach allows us to achieve quality and speed that are simply beyond traditional human capabilities alone. By keeping domain experts at the center of the workflow, we guarantee that every deliverable is regulator-ready and of the highest professional standard.
Join over 1,000 pharmaceutical leaders who trust Deep Intelligent Pharma for their most critical documentation needs.
Get Started Now